Histologic changes in the breast with menopausal hormone therapy use
- 1 January 2008
- journal article
- Published by Wolters Kluwer Health in Menopause
- Vol. 15 (1) , 67-73
Abstract
This retrospective study systematically compared mammographic density with histology in women receiving or not receiving menopausal hormone therapy (HT). This study was approved by the institutional review board. Twenty-eight postmenopausal women using HT were matched with 28 postmenopausal women not using HT at the time of breast cancer diagnosis. Noncancerous tissue from mastectomy specimens was examined histologically to quantitate the content of fibrous stroma, ducts, and lobule types 1, 2, and 3. Tissue samples were also evaluated for estrogen receptor, progesterone receptor, and Ki67 activity in the ducts and lobules. Breast density was quantified by digitizing the contralateral mammogram and computer-assisted interactive thresholding. High breast density in women using HT was correlated with greater fibrous stroma (P = 0.020) and lobule type 1 (P = 0.016). Breast density also correlated with Ki67 activity in the ducts (P = 0.031) and lobules (P= 0.023) for both groups combined. Estrogen and progesterone receptors did not correlate with either breast density or HT use. Increased fibrous stroma and lobule type 1 are associated with increasing mammographic density in women using HT, independent of estrogen and progesterone receptor up-regulation. These findings suggest that increased breast density may be mediated through a paracrine effect. The increase in breast cancer risk with HT use may be due to an increase in target lobule type 1 cells.Keywords
This publication has 39 references indexed in Scilit:
- Epithelial–stromal interactions in the mouse and human mammary gland in vivoEndocrine-Related Cancer, 2004
- Role of Fibroblast Growth Factor-2 Isoforms in the Effect of Estradiol on Endothelial Cell Migration and ProliferationCirculation Research, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Breast cancer and hormone-replacement therapy: the Million Women StudyThe Lancet, 2003
- Breast cancer and hormone-replacement therapy in the Million Women StudyThe Lancet, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Effects of Estrogen and Estrogen–Progestin on Mammographic Parenchymal DensityAnnals of Internal Medicine, 1999
- Control of aromatase activity in breast tumours: the role of the immune systemThe Journal of Steroid Biochemistry and Molecular Biology, 1997
- Quantitative Classification of Mammographic Densities and Breast Cancer Risk: Results From the Canadian National Breast Screening StudyJNCI: Journal of the National Cancer Institute, 1995
- The dense mammogramAmerican Journal of Roentgenology, 1986